Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials

Published:2020-08-07 Issue:8 Volume:3 Page:e2012534
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Yang Fang¹,Markovic Svetomir N.²,Molina Julian R.²,Halfdanarson Thorvardur R.²,Pagliaro Lance C.²,Chintakuntlawar Ashish V.²,Li Rutian¹,Wei Jia¹,Wang Lifeng¹,Liu Baorui¹,Nowakowski Grzegorz S.³,Wang Michael L.⁴,Wang Yucai³

Affiliation:

1. The Comprehensive Cancer Center of Drum Tower Hospital, Clinical Cancer Institute of Nanjing University, Nanjing, China

2. Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota

3. Division of Hematology, Mayo Clinic, Rochester, Minnesota

4. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2769134/yang_2020_oi_200474.pdf

Reference59 articles.

1. Cancer immunotherapy using checkpoint blockade.;Ribas;Science,2018

2. Sex differences in immune responses.;Klein;Nat Rev Immunol,2016

3. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA.;Agrawal;J Immunol,2009

4. Characterization of lung inflammation and its impact on macrophage function in aging.;Canan;J Leukoc Biol,2014

5. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood.;Jing;Hum Immunol,2009

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores;Cancer Medicine;2024-08

2. Does patient sex affect the treatment outcome of immune checkpoint inhibitors? A Danish, observational melanoma study;European Journal of Cancer;2024-07

3. Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective;Expert Review of Gastroenterology & Hepatology;2024-06-02

4. The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis;Expert Review of Anticancer Therapy;2024-04-16

5. Outcome differences by sex in oncology clinical trials;Nature Communications;2024-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3